Shelby Knowles / Bloomberg via Getty Images Eli Lilly's Zepbound can be covered by Medicare Part D plans after the FDA approved the drug as a treatment for sleep apnea last month. Weight loss ...

it’s veteran Denico Autry, who had a sack and four total pressures against Justin Herbert and the Chargers. The veteran has been in the league since catching on with the then-Oakland Raiders and ...

Shares of Eli Lilly have been falling in recent months, but that could spell opportunity. Investors appear to be concerned that a new government could impact its growth potential. The business is ...

Dobbins, receiver Quentin Johnston (thigh, illness) and cornerback Eli Apple (hamstring ... Four Texans are questionable: defensive end Denico Autry (knee), linebacker Christian Harris (ankle ...

What will Eli Lilly do with all its cash from Mounjaro and Zepbound? What does CEO Dave Ricks think it would take for the company to reach a $1 trillion market capitalization? And how does Ricks ...

Apple (AAPL) closed at $237.87 in the latest trading session, marking a +1.97% move from the prior day. The stock's performance was ahead of the S&P 500's daily gain of 1.83%. Meanwhile, the Dow ...

Eli Lilly spooked the market with warnings of a small revenue slowdown in Q4 2024. Lilly nevertheless delivered good news about its prospects for sales growth in 2025. The company also dropped a ...

Investing.com -- Eli Lilly and Company (NYSE:LLY) has projected its full-year global revenue for 2024 to reach around $45 billion, marking a 32% increase from the prior year. The company also ...

This mandatory process, managed by the Employees’ Provident Fund Organisation (EPFO), is crucial for accessing the benefits of the ELI Scheme. Announced by Finance Minister Nirmala Sitharaman in ...

SAN FRANCISCO — Eli Lilly CEO Dave Ricks on Tuesday said he believed the company could find “significant common cause” with the incoming Trump administration, including on issues around ...

Apple AAPL3.49%increase; green up pointing triangle is defending itself in the first hearing of a $1.8 billion U.K. class action lawsuit accusing the iPhone maker of abusing its dominance in the ...

Eli Lilly has agreed to acquire Scorpion Therapeutics’ breast cancer treatment program for up to $2.5 billion in cash. The drugmaker said Monday it is acquiring Scorpion and its STX-478 program ...